De Toni-Debré-Fanconi syndrome in a patient with Kearns-Sayre syndrome: A case report

Journal of Medical Case Reports

Volumn 3, Issue , 2009, Pages

  Mihai, Cristina Maria ^a   Catrinoiu, Doina ^a   Toringhibel, Marius ^a   Stoicescu, Ramona Mihaela ^a   Hancu, Anca ^a  

^a OVIDIUS UNIVERSITY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72849112560     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-3-101     Document Type: Article

References (19)

1. Mitochondrial encephalomyopathies: therapeutic approaches. S DiMauro M Hirano EA Schon, Neurol Sci 2000 21 901 S908
2. Treatment of Kearns-Sayre syndrome with coenzyme Q10. S Ogasahara Y Nishikawa S Yorifuji F Soga Y Nakamura M Takahashi S Hashimoto N Kono S Tarui, Neurology 1986 36 1 45 53
3. Retinitis pigmentosa, external ophthalmoplegia, and complete heart block: unusual syndrome with histologic study in one of two cases. TP Kearns G Sayre, Arch Ophthalmol 1958 6 280 289
4. VA McKusick, Online Mendelian Inheritance in Man (OMIM) Baltimore. MD: The Johns Hopkins University; Entry No: 530000
5. Spontaneous Kearns-Sayre syndrome/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. JM Shoffner MT Lott AS Voljavec, Proc Natl Acad Sci USA 1989 86 7952 7956
6. Kearns-Sayre syndrome with a novel mitochondrial DNA deletion. J Marin-Garcia MJ Goldenthal HB Sarnat, J Child Neurol 2000 15 555 558
7. Progressive ptosis in children as a presenting sign of Kearns-Sayre syndrome. R Gal, Harefuah 2000 138 108 110
8. Advantages of insulin Lispro (short-acting) in terminal kidney failure. PM Jehle U Aisenpreis D Bundschu F Keller, Fortschr Med 1999 117 11 41 42
9. Kearns-Sayre syndrome. hypoparathyroidism and basal ganglia calcification. AG Dewhurst D Hall MS Schwartz RO McKeran, J Neurol Neurosurg Psychiatr 1986 49 1323 1324
10. Endocrine dysfunction in Kearns-Sayre syndrome. JN Harvey D Barnett, Clin Endocrinol (Oxf) 1992 37 1 97 103
11. Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNA deletion. H Isotani Y Haruhiko Fukumoto H Kawamura K Furukawa N Ohsawa Y Goto I Nishino I Nonaka, Clin Endocrinol 1996 45 5 637 641
12. Patient with Fanconi Syndrome (FS) and retinitis pigmentosa (RP) caused by a deletion and duplication of mitochondrial DNA (mtDNA). EM Pitchon F Cachat S Jacquemont C Hinard FX Borruat DF Schorderet MA Morris FL Munier, Klin Monatsbl Augenheilkd 2007 224 4 340 343
13. Therapeutic approach in a case of Pearson's syndrome. M Zaffanello G Zamboni, Minerva Pediatr 2005 57 3 143 146
14. Kearns-Sayre syndrome associated with de Toni-Debré-Fanconi syndrome due to cytochrome-c-oxidase (COX) deficiency. A Berio A Piazzi, Panminerva Med 2001 43 3 211 214
15. Mitochondrial encephalomyopathies preceded by de-Toni-Debré- Fanconi syndrome or focal segmental glomerulosclerosis. H Mochizuki K Joh H Kawame A Imadachi H Nozaki T Ohashi N Usui Y Eto Y Kanetsuna S Aizawa, Clin Nephrol 1996 4 5 347 352
16. Renal and skin involvement in a patient with complete Kearns-Sayre syndrome. K Mori K Narahara S Ninomiya Y Goto I Nonaka, Am J Med Genet 1991 38 4 583 587
17. Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. Y Goto N Itami N Kajii H Tochimaru M Endo S Horai, J Pediatr 1990 116 6 904 910
18. Primary Toni-Debré-Fanconi syndrome. A Berio, Pediatr Med Chir 1993 15 1 79 85
19. Mitochondrial cytopathy with lactic acidosis, carnitine deficiency and De Toni-Fanconi-Debre syndrome. A Kitano S Nishiyama T Miike S Hattori Y Ohtani I Matsuda, Brain Dev 1986 8 3 289 295